이 단백질은 알데히드 탈수소효소 단백질군에 속한다.이 유전자는 미토콘드리아 NAD 의존성+숙신성 세미알데히드 탈수소효소를 인코딩한다.이 효소의 결핍은 4-하이드록시부티리쿠리아라고 알려져 있는데, 신경전달물질인 γ-아미노부티리산(GABA)의 신진대사에 있어서 드물게 선천적인 오류다.이 결함에 대응하여 환자의 생리학적 액체는 수많은 신경 조절 특성을 가진 화합물인 GHB를 축적한다.이 유전자에 대해 구별되는 ISO 양식을 인코딩하는 두 가지 대본 변형이 확인되었다.[7]
Hearl WG, Churchich JE (Sep 1984). "Interactions between 4-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase, two mitochondrial enzymes". The Journal of Biological Chemistry. 259 (18): 11459–63. PMID6470007.
Hogema BM, Akaboshi S, Taylor M, Salomons GS, Jakobs C, Schutgens RB, Wilcken B, Worthington S, Maropoulos G, Grompe M, Gibson KM (Mar 2001). "Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses". Molecular Genetics and Metabolism. 72 (3): 218–22. doi:10.1006/mgme.2000.3145. PMID11243727.
Aoshima T, Kajita M, Sekido Y, Ishiguro Y, Tsuge I, Kimura M, Yamaguchi S, Watanabe K, Shimokata K, Niwa T (2002). "Mutation analysis in a patient with succinic semialdehyde dehydrogenase deficiency: a compound heterozygote with 103-121del and 1460T > A of the ALDH5A1 gene". Human Heredity. 53 (1): 42–4. doi:10.1159/000048603. PMID11901270. S2CID25065695.
Blasi P, Boyl PP, Ledda M, Novelletto A, Gibson KM, Jakobs C, Hogema B, Akaboshi S, Loreni F, Malaspina P (Aug 2002). "Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms". Molecular Genetics and Metabolism. 76 (4): 348–62. doi:10.1016/S1096-7192(02)00105-1. PMID12208142.
Novikov VD, Valova TA, Iasakova NT, Belan IB (2003). "[Morphological and functional characteristics of lymphocytes of mothers of children with Down syndrome]". Morfologii͡A. 118 (4): 74–80. PMID12629812.
Akaboshi S, Hogema BM, Novelletto A, Malaspina P, Salomons GS, Maropoulos GD, Jakobs C, Grompe M, Gibson KM (Dec 2003). "Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency". Human Mutation. 22 (6): 442–50. doi:10.1002/humu.10288. hdl:2108/48106. PMID14635103. S2CID20057400.
Kang JH, Park YB, Huh TL, Lee WH, Choi MS, Kwon OS (Nov 2005). "High-level expression and characterization of the recombinant enzyme, and tissue distribution of human succinic semialdehyde dehydrogenase". Protein Expression and Purification. 44 (1): 16–22. doi:10.1016/j.pep.2005.03.019. PMID16199352.
Knerr I, Pearl PL, Bottiglieri T, Snead OC, Jakobs C, Gibson KM (Jun 2007). "Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology". Journal of Inherited Metabolic Disease. 30 (3): 279–94. doi:10.1007/s10545-007-0574-2. PMID17457693. S2CID20004337.